Merck & Co Inc (NYSE:MRK)

90.97
Delayed Data
As of Jan 17
 -0.21 / -0.23%
Today’s Change
72.05
Today|||52-Week Range
92.64
+0.02%
Year-to-Date
Here's Why Clovis Oncology Rose as Much as 25.6% Today
Jan 15 / MotleyFool.com - Paid Partner Content
The Risk of Cancer-Related Death Is Dropping Faster Than Ever
Jan 08 / MotleyFool.com - Paid Partner Content
FDA Gives Clovis Oncology's Rubraca a Priority Review
Jan 15 / MotleyFool.com - Paid Partner Content
Dollar Tree Stock Is Down 20%, But Investors Should Reject Mini-Tender Offer
Jan 08 / MotleyFool.com - Paid Partner Content
Better Buy: Johnson & Johnson vs. Merck
Jan 15 / MotleyFool.com - Paid Partner Content
Merck's Keytruda Misses an Important Lung Cancer Goal
Jan 07 / MotleyFool.com - Paid Partner Content
Merck's Blockbuster Drug Wins Key New FDA Approval
Jan 08 / MotleyFool.com - Paid Partner Content